Defunct Company
Total Trials
14
As Lead Sponsor
11
As Collaborator
3
Total Enrollment
3,593
NCT03008954
Effect of GSP3 on Body Weight in Overweight and Obese Subjects
Phase: N/A
Role: Lead Sponsor
Start: Jul 31, 2012
Completion: Feb 28, 2013
NCT02307279
Study of Gelesis100 on Body Weight in Overweight and Obese Subjects With and Without Type 2 Diabetes
Start: Nov 30, 2014
Completion: Jun 30, 2017
NCT02487602
A Scintigraphic Study to Investigate the Effect of Gelesis100 on Gastric Emptying in Overweight and Obese Subjects
Start: Sep 30, 2015
Completion: Jul 31, 2016
NCT02524821
The Effect of Gelesis100 on the Pharmacokinetics of Metformin
Completion: Dec 31, 2015
NCT02652962
Gelesis200 Safety and Tolerability Study and Effects on Glycemic and Appetite Parameters
Start: Jan 31, 2016
Completion: Mar 31, 2016
NCT03021291
Extension Study of Gelesis100 on Body Weight
Start: Jan 25, 2017
Completion: Dec 15, 2017
NCT03058029
Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects w/o Type 2 Diabetes
Start: Feb 22, 2017
Completion: Jan 15, 2021
NCT03054506
The Effect of CSP01 on Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation
Role: Collaborator
Start: Mar 7, 2017
Completion: Feb 1, 2019
NCT03124134
Gelesis Glycemic Index Study
Start: Apr 18, 2017
Completion: May 18, 2017
NCT03622424
Effects of Gelesis200 on Appetite Parameters, Food Intake, and Glycemic Control in Overweight or Obese Prediabetic Subjects: A Sub-Study of LIGHT-UP
Start: Aug 22, 2017
Completion: Dec 20, 2019
NCT04257123
SATISFY (geleSis100 Effects on AppeTIte Sensations, Feeding Behavior and Dietary energY)
Start: Jan 7, 2020
Completion: Dec 31, 2021
NCT05520801
Primary Hepatobiliary Cancer Cohort of Central China
Start: May 1, 2020
Completion: Mar 31, 2025
NCT04887766
Study on GS300 on NAFLD
Start: Jul 1, 2022
Completion: Dec 31, 2023
NCT04887896
Assessing GS500 in Functional Constipation
Start: Jul 15, 2022
Completion: Dec 30, 2023